Explore the full record of transactions filed by GUGGENHIME ANDREW, Chief Financial Officer. Insider active across 1 companies, notably Vaxcyte, Inc.. Cumulatively, 9 disclosures have been logged. The latest transaction was disclosed on 18 May 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
GUGGENHIME ANDREW is the President and Chief Financial Officer of Vaxcyte, Inc. He oversees the company's financial management, including budgeting and performance analysis.